Identification of Pancreatic Cancer in Biliary Obstruction Patients by FRY Site-specific Methylation

  • Angsuwatcharakon, Phonthep (Excellence Center for Gastrointestinal Endoscopy King Chulalongkorn Memorial Hospital) ;
  • Rerknimitr, Rungsun (Excellence Center for Gastrointestinal Endoscopy King Chulalongkorn Memorial Hospital) ;
  • Kongkam, Pradermchai (Excellence Center for Gastrointestinal Endoscopy King Chulalongkorn Memorial Hospital) ;
  • Ridtitid, Wiriyaporn (Excellence Center for Gastrointestinal Endoscopy King Chulalongkorn Memorial Hospital) ;
  • Ponauthai, Yuwadee (Excellence Center for Gastrointestinal Endoscopy King Chulalongkorn Memorial Hospital) ;
  • Srisuttee, Ratakorn (Center of Excellence in Molecular Genetics of Cancer and Human Disease, Faculty of Medicine, Chulalongkorn University) ;
  • Kitkumthorn, Nakarin (Department of Oral Biology, Faculty of Dentistry, Mahidol University) ;
  • Mutirangura, Apiwat (Department of Anatomy, Faculty of Medicine, Chulalongkorn University)
  • Published : 2016.09.01

Abstract

Background: Methylation at cg 16941656 of FRY is exclusively found in normal pancreatic tissue and has been proven to be specific for pancreatic-in-origin among several adenocarcinomas. Here, we investigated methylated DNA in the bile as a biomarker to differentiate the cause of obstruction between pancreatic cancer and benign causes. Materials and Methods: Bile samples of 45 patients with obstructive jaundice who underwent ERCP were collected and classified into pancreatic cancer (group 1) and benign causes (group 2) in 24 and 21 patients, respectively. DNA was extracted from bile and bisulfite modification was performed. After, methylation in cg 16941656 of FRY was identified by real-time PCR, with beta-actin used as a positive control. Results: Methylated DNA was identified in 10/24 (41.67%) and 1/21 (4.8%) of cases in groups 1 and 2, respectively (P= 0.012). The sensitivity, specificity, positive predictive value and negative predictive value to differentiate pancreatic cancer from benign causes were 42%, 95%, 91%, and 59%, respectively. Conclusions: Detecting a methylation at cg 16941656 of FRY in bile has high specificity, with an acceptable positive likelihood rate, and may therefore be helpful in distinguish pancreatic cancer from benign strictures.

Keywords

Acknowledgement

Supported by : Chulalongkorn University

References

  1. Allescher HD (1989). Papilla of Vater: structure and function. Endoscopy, 21, 324-9. https://doi.org/10.1055/s-2007-1012982
  2. Anonymous (2010). AJCC Cancer Staging Manual, Springer- Verlag New York.
  3. Bibikova M, Le J, Barnes B, et al (2009). Genome-wide DNA methylation profiling using Infinium(R) assay. Epigenomics, 1, 177-200. https://doi.org/10.2217/epi.09.14
  4. Budzynska A, Nowakowska-Dulawa E, Marek T, et al (2013). Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin. J Physiol Pharmacol, 64, 109-14.
  5. Farina A, Dumonceau JM, Antinori P, et al (2014). Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses. Biochim Biophys Acta, 1844, 1018-25. https://doi.org/10.1016/j.bbapap.2013.06.010
  6. Goral V (2015). Pancreatic Cancer: Pathogenesis and Diagnosis. Asian Pac J Cancer Prev, 16, 5619-24. https://doi.org/10.7314/APJCP.2015.16.14.5619
  7. Hadizadeh M, Padashi M, Mohammad Alizadeh AH, et al (2014). Clinical, laboratory biomarkers and imaging findings of pancreatic adenocarcinoma in Iran. Asian Pac J Cancer Prev, 15, 4349-52. https://doi.org/10.7314/APJCP.2014.15.10.4349
  8. Katanuma A, Maguchi H, Hashigo S, et al (2012). Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy, 44, 160-1. https://doi.org/10.1055/s-0031-1291716
  9. Kisiel JB, Raimondo M, Taylor WR, et al (2015). New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clin Cancer Res, 21, 4473-81. https://doi.org/10.1158/1078-0432.CCR-14-2469
  10. Lourdusamy V, Tharian B, Navaneethan U (2015). Biomarkers in bile-complementing advanced endoscopic imaging in the diagnosis of indeterminate biliary strictures. World J Gastrointest Endosc, 7, 308-17. https://doi.org/10.4253/wjge.v7.i4.308
  11. Majumder S, Chari ST, Ahlquist DA (2015). Molecular detection of pancreatic neoplasia: Current status and future promise. World J Gastroenterol, 21, 11387-95. https://doi.org/10.3748/wjg.v21.i40.11387
  12. Muangsub T, Samsuwan J, Tongyoo P, et al (2014). Analysis of methylation microarray for tissue specific detection. Gene, 553, 31-41. https://doi.org/10.1016/j.gene.2014.09.060
  13. Navaneethan U, Njei B, Lourdusamy V, et al (2015). Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc, 81, 168-76. https://doi.org/10.1016/j.gie.2014.09.017
  14. Pai AA, Bell JT, Marioni JC, et al (2011). A genome-wide study of DNA methylation patterns and gene expression levels in multiple human and chimpanzee tissues. PLoS Genet, 7, 1001316. https://doi.org/10.1371/journal.pgen.1001316
  15. Patel AH, Harnois DM, Klee GG, et al (2000). The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 95, 204-7. https://doi.org/10.1111/j.1572-0241.2000.01685.x
  16. Sadeghi A, Mohamadnejad M, Islami F, et al (2016). Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest Endosc, 83, 290-8 e1. https://doi.org/10.1016/j.gie.2015.09.024
  17. Salehimarzijarani B, Dadvar Z, Mousavi M, et al (2012). Risk factors for post-ERCP cholangitis in patients with pancreatic cancer from a single referral center in Iran. Asian Pac J Cancer Prev, 13, 1539-41. https://doi.org/10.7314/APJCP.2012.13.4.1539
  18. Shen J, Wang S, Zhang YJ, et al (2012). Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatol, 55, 1799-808. https://doi.org/10.1002/hep.25569
  19. Srisuttee R, Ota J, Muangsub T, et al (2016). FRY site-specific methylation differentiates pancreatic ductal adenocarcinoma from other adenocarcinomas. APMIS. 124, 469-474. https://doi.org/10.1111/apm.12527
  20. Zabron AA, Horneffer-van der Sluis VM, Wadsworth CA, et al (2011). Elevated levels of neutrophil gelatinaseassociated lipocalin in bile from patients with malignant pancreatobiliary disease. Am J Gastroenterol, 106, 1711-7. https://doi.org/10.1038/ajg.2011.187